You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 57 Next »

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka (AbbVie)

melvin.munsaka@abbvie.com

Terry Walsh (Astellas)

terry.walsh@astellas.com

Nicola Newton (PHUSE, Project Assistant)

nicky@phuse.global

CURRENT STATUS Q1 2023

Working on a White Paper

Objectives & Deliverables

Timelines 

Finalise stage 1 of draft White Paper for Public Review

Q2 2023
  • No labels